Research? - (Relief associated)

  1. Skelley, J. W., Deas, C. M., Curren, Z., & Ennis, J. (2020). Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association, 60(1), 253–261.

  2. Cascio, M. G., Gauson, L. A., Stevenson, L. A., Ross, R. A., & Pertwee, R. G. (2009). Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. British Journal of Pharmacology, 159(1), 129–141.

  3. Croteau, E., Castellano, C.-A., Richard, M. A., Fortier, M., Nugent, S., Lepage, M., Duchesne, S., Whittingstall, K., Turcotte, É. E., Bocti, C., Fülöp, T., &; Cunnane, S. C. (2018). Ketogenic medium chain triglycerides increase brain energy metabolism in alzheimer’s disease. Journal of Alzheimer's Disease, 64(2), 551–561.

  4. Anand, U., Jones, B., Korchev, Y., Bloom, S. R., Pacchetti, B., Anand, P., & Sodergren, M. H. (2020). CBD effects on TRPV1 signaling pathways in cultured DRG neurons. Journal of Pain Research, Volume 13, 2269–2278.

  5. Evans, F. (1991). Cannabinoids: The separation of central from peripheral effects on a structural basis. Planta Medica, 57(S 1).

  6. Russo E. B. (2008). Cannabinoids in the management of difficult to treat pain. Therapeutics and clinical risk management, 4(1), 245–259.

  7. Yu, S., Go, G. W., & Kim, W. (2019). Medium Chain Triglyceride (MCT) Oil Affects the Immunophenotype via Reprogramming of Mitochondrial Respiration in Murine Macrophages. Foods (Basel, Switzerland), 8(11), 553.

  8. Martina Cirlini, Pedro Mena, Michele Tassotti, Kelli A Herrlinger et al. (2016). Phenolic and Volatile Composition of a Dry Spearmint (Mentha spicata L.) Extract. Molecules, 3;21(8).

Solo Hemp Relief

for more information feel free to reach out at